Mylotarg
FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia »
"The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
ALL is the most common type of pediatric "...
Read the FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia article »
Mylotarg
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.
Last reviewed on RxList: 6/24/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Mylotarg Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
